SecBot SecBot
SECBOTREPLAY Home › Report › CRBU

CRBU · Caribou Biosciences is holding its 2026 annual meeting where…

Caribou Biosciences, Inc. · DEFA14A filed Apr 24, 2026 at 16:01 ET

At the news

NEUTRALIMPACT 3/10

DEFA14A filed Apr 24, 2026 at 16:01 ET

Caribou Biosciences is holding its 2026 annual meeting where shareholders will vote on electing three Class II directors, ratifying Deloitte & Touche LLP as auditors, approving an amendment to exculpate officers from certain fiduciary duties, and adjourning the meeting if needed. This is a routine annual shareholder meeting with no material financial impact.

  • Election of three Class II directors: Andrew Guggenhime, David Johnson, and Nancy Whiting
  • Ratification of Deloitte & Touche LLP as independent registered public accounting firm for 2026
  • Approval of amendment to provide for exculpation of officers from certain breaches of fiduciary duty
  • Approval of adjourning the 2026 Annual Meeting if necessary for further solicitation of proxies

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access